Published in Immunogenetics on March 10, 2010
The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine (2011) 1.24
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS (2011) 1.21
The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet (2011) 1.17
Rubella. Lancet (2015) 1.16
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine (2011) 1.12
Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans. J Infect Dis (2011) 1.09
Technical and biological variance structure in mRNA-Seq data: life in the real world. BMC Genomics (2012) 1.03
Vaccines, reverse vaccinology, and bacterial pathogenesis. Cold Spring Harb Perspect Med (2013) 1.01
Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment. BMC Immunol (2010) 1.00
High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers. Clin Vaccine Immunol (2014) 0.96
Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One (2013) 0.95
Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J (2011) 0.93
Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts. Vaccine (2014) 0.90
Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine (2012) 0.86
Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts. Immunol Res (2014) 0.83
Evolutional and clinical implications of the epigenetic regulation of protein glycosylation. Clin Epigenetics (2011) 0.82
Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination. Hum Genet (2014) 0.81
Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients. Immunogenetics (2014) 0.80
Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. J Infect Dis (2014) 0.80
Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. PLoS One (2014) 0.80
Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age. Vaccine (2011) 0.78
Recent Advances in Application of Pharmacogenomics for Biotherapeutics. AAPS J (2016) 0.75
Genetics and vaccines in the era of personalized medicine. Curr Genomics (2015) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52
Replicating genotype-phenotype associations. Nature (2007) 16.11
A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med (2007) 8.97
Nomenclature for the description of human sequence variations. Hum Genet (2001) 7.90
The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol (2009) 3.72
Genetic associations in large versus small studies: an empirical assessment. Lancet (2003) 3.41
Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol (2005) 3.17
Cytokine gene polymorphism in human disease: on-line databases. Genes Immun (1999) 2.86
Inflaming the CD8+ T cell response. Immunity (2006) 2.44
The immunogenetics of smallpox vaccination. J Infect Dis (2007) 2.23
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther (2007) 2.17
Regulation of the T cell response. Clin Exp Allergy (2006) 2.16
Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest (1989) 2.08
Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol (2008) 2.04
Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun (2001) 1.94
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J Exp Med (2008) 1.89
Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev (2008) 1.85
Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol (2000) 1.74
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med (2009) 1.72
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics (2008) 1.41
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis (2006) 1.35
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis (2005) 1.35
Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun (2002) 1.31
Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens (2008) 1.26
Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun (2006) 1.24
The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA (2002) 1.21
Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med (2000) 1.19
Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One (2008) 1.16
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS (2008) 1.14
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine (2009) 1.10
Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods (2008) 1.09
Tumor necrosis factor and interferon: cytokines in harmony. Curr Opin Microbiol (2008) 1.08
A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics (2001) 1.07
The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol (2002) 1.07
Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine (2010) 1.06
Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Vaccine (1995) 1.05
Interleukin 17 modulates the immune response to vaccinia virus infection. Virology (2002) 1.03
Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics (2003) 1.02
A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology (2005) 1.02
Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun (2001) 1.01
Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. J Clin Invest (2008) 0.97
The relevance of cytokines for development of protective immunity and rational design of vaccines. Cytokine Growth Factor Rev (2007) 0.96
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine (2000) 0.94
Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines. J Virol (1984) 0.94
HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. Vaccine (2009) 0.94
Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine. Vaccine (1984) 0.93
Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer. Vaccine (1999) 0.92
Genetic association analysis: a primer on how it works, its strengths and its weaknesses. Int J Androl (2008) 0.92
Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age. Indian J Med Res (1994) 0.91
Elevated serum levels of interleukin-10 in children with acute rubella infection. Scand J Infect Dis (2001) 0.90
Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics (2003) 0.90
Analysis of gene expression in fetal and adult cells infected with rubella virus. Virology (2007) 0.90
1. Lymphocytes. J Allergy Clin Immunol (2008) 0.89
Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination. Mediators Inflamm (2003) 0.86
2',5'-Oligoadenylate synthetase and interferon in peripheral blood after rubella, measles, or mumps live virus vaccine. Proc Soc Exp Biol Med (1987) 0.86
Persistence of vaccine-induced immune responses to rubella: comparison with natural infection. Rev Infect Dis (1985) 0.83
Production of interferon by human peripheral lymphocytes stimulated with rubella virus. Kitasato Arch Exp Med (1988) 0.80
Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells. Microbes Infect (2003) 0.79
Replication of rubella virus in human mononuclear blood cells. Infect Immun (1980) 0.78
Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility. Ann N Y Acad Sci (2008) 0.78
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med (2010) 3.40
Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol (2008) 2.97
Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol (2006) 2.38
A program of anticipatory guidance for the prevention of emergency department visits for ear pain. Arch Pediatr Adolesc Med (2008) 2.36
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA (2003) 2.15
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Developing the next generation of vaccinologists. Vaccine (2010) 2.07
Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol (2008) 2.06
Population-based prevalence of repeated group A beta-hemolytic streptococcal pharyngitis episodes. Mayo Clin Proc (2006) 2.03
Vaccine immunogenetics: bedside to bench to population. Vaccine (2008) 2.01
Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics (2013) 2.01
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics (2002) 1.98
Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev (2005) 1.81
The age-old struggle against the antivaccinationists. N Engl J Med (2011) 1.80
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med (2006) 1.77
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev (2007) 1.75
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol (2010) 1.70
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat (2010) 1.70
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res (2011) 1.64
Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis (2009) 1.64
Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine (2008) 1.60
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med (2004) 1.59
Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther (2008) 1.59
Vaccines against avian influenza--a race against time. N Engl J Med (2006) 1.57
Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine (2005) 1.55
Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis (2006) 1.54
Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol (2006) 1.50
Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol (2008) 1.50
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res (2011) 1.47
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet (2009) 1.46
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology (2016) 1.45
p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila) (2011) 1.45
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. Paediatr Perinat Epidemiol (2007) 1.45
Independence of measles-specific humoral and cellular immune responses to vaccination. Hum Immunol (2012) 1.44
Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome? Medicine (Baltimore) (2008) 1.43
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res (2008) 1.42
If you could halve the mortality rate, would you do it? Clin Infect Dis (2002) 1.42
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet (2009) 1.42
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics (2008) 1.41
The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40
Confronting bioterrorism: physicians on the front line. Mayo Clin Proc (2002) 1.40
Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J (2013) 1.40
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.39
Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39
Gender effects on humoral immune responses to smallpox vaccine. Vaccine (2009) 1.39